GW PHARMACEUTICALS PLC (18) | Uncategorized (8)

Recent Contracts

Offer Letter, dated February 25, 2021 between Greenwich Biosciences, Inc. and Justin Gover (Filed With SEC on February 26, 2021)
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 26, 2021)
Letter of Appointment by and between GW Pharmaceuticals plc and Justin Gover, dated February 25, 2021 (Filed With SEC on February 26, 2021)
Transaction Agreement, dated as of February 3, 2021, by and among GW Pharmaceuticals plc, Jazz Pharmaceuticals UK Holdings Limited and Jazz Pharmaceuticals Public Limited Company (Filed With SEC on February 3, 2021)
Letter of Appointment by and between GW Pharmaceuticals plc and David Gryska, dated September 9, 2020 (Filed With SEC on November 5, 2020)
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
PRV Transfer Agreement, dated March 15, 2019, by and between GW Research Ltd. and Biohaven Pharmaceutical Holding Ltd (Filed With SEC on May 8, 2019)
Offer letter by and between Greenwich Biosciences, Inc. and Darren Cline (Filed With SEC on April 12, 2019)